13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D Filed 2026-09-09 Event 2026-08-20 SEC 0001178913-26-004462 →

Arkin Moshe Odysight.ai Inc. ODYS

Stake: 33.34% Shares: 4,135,724 CUSIP: 81063V204 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

The Reporting Persons intend to review the performance of their investment in the Issuer from time to time. Depending on various factors, including the business, prospects and financial position of the Issuer, the current and anticipated future price levels of the Common Stock and currency exchange rates, the conditions in the securities markets and general economic and industry conditions, as well as the other investment opportunities available to them, each of the Reporting Persons will take such actions with respect to their investment in the Issuer as they deem appropriate in light of the circumstances existing from time to time. Each of the Reporting Persons may purchase additional equity in the Issuer or may, and hereby reserve the right to, dispose of some or all of their holdings in the open market, in public offerings, in privately negotiated transactions or in other transactions, including swaps and other derivative transactions, subject to applicable securities laws. Other than as described above, neither of the Reporting Persons has any plans or proposals that relate to or would result in any of the actions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D (although each Reporting Person reserves the right to develop such plans).

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
10 filings by this filer
9 other filings in the data moat
Short Interest · settle 2026-08-31
DTC 1.00
22,517 shares short · +0.4% vs prior

Other Filings by Arkin Moshe

FiledFormIssuerStakeShares
2024-07-01 SC Eiger BioPharmaceuticals, Inc. view →
2024-04-08 SC Sol-Gel Technologies Ltd. SLGL view →
2023-03-20 SC Sol-Gel Technologies Ltd. SLGL view →
2020-12-17 SC Keros Therapeutics, Inc. KROS view →
2020-11-25 SC Keros Therapeutics, Inc. KROS view →
2020-04-20 SC Sol-Gel Technologies Ltd. SLGL view →
2019-12-19 SC Aclaris Therapeutics, Inc. ACRS view →
2019-11-21 SC Aclaris Therapeutics, Inc. ACRS view →
2019-06-03 SC UroGen Pharma Ltd. URGN view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →